Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Syros Pharmaceuticals, Inc. SYRS

Full chart Compare
Set alert

Price alert · SYRS

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 4, 2026, 4:00 PM EST

0.11 +0.11 +26,700.00%

After hours · Nov 4, 4:00 PM ET

0.0005 Day range 0.0005
0.0001 52-week range 0.02
YTD
+14.29%
1 year
-33.33%

Financial health

Altman Z-Score

-15.54 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

0 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.3×
FY 2014: -3.3×FY 2015: -1.5×FY 2016: -3.2×FY 2017: -4.6×FY 2018: -2.9×FY 2019: -3.7×FY 2020: -5.9×FY 2021: -2.4×FY 2022: -0.5×FY 2023: -1.3×
FY 2014 5y median -2.4× FY 2023
P/S 22.2×
FY 2014: 0.0×FY 2015: 142×FY 2016: 487×FY 2017: 225×FY 2018: 88.7×FY 2019: 140×FY 2020: 33.1×FY 2021: 8.7×FY 2022: 3.0×FY 2023: 22.2×
FY 2014 5y median 22.2× FY 2023
P/B 13.2×
FY 2014: 0.7×FY 2015: 1.3×FY 2016: 1.9×FY 2017: 3.8×FY 2018: 2.3×FY 2019: 3.5×FY 2020: 5.5×FY 2021: 2.4×FY 2022: 0.4×FY 2023: 13.2×
FY 2014 5y median 3.5× FY 2023
P/FCF -2.0×
FY 2014: -3.7×FY 2015: -1.9×FY 2016: -3.6×FY 2017: -5.4×FY 2018: -4.4×FY 2019: -3.8×FY 2020: -8.2×FY 2021: -2.0×FY 2022: -0.4×FY 2023: -2.0×
FY 2014 5y median -2.0× FY 2023
EV/EBITDA -0.9×
FY 2014: 1.2×FY 2015: -0.3×FY 2016: -2.1×FY 2017: -4.0×FY 2018: -2.2×FY 2019: -3.6×FY 2020: -4.9×FY 2021: -2.2×FY 2022: 0.7×FY 2023: -0.9×
FY 2014 5y median -2.2× FY 2023
EV/Sales 14.4×
FY 2014: 0.0×FY 2015: 29.5×FY 2016: 303×FY 2017: 195×FY 2018: 64.4×FY 2019: 132×FY 2020: 26.0×FY 2021: 7.5×FY 2022: -3.9×FY 2023: 14.4×
FY 2014 5y median 14.4× FY 2023
FCF Yield -49.8%
FY 2014: -27.1%FY 2015: -53.9%FY 2016: -27.8%FY 2017: -18.4%FY 2018: -22.9%FY 2019: -26.2%FY 2020: -12.1%FY 2021: -49.4%FY 2022: -274.1%FY 2023: -49.8%
FY 2014 5y median -49.4% FY 2023

Profitability

Gross Margin 77.3%
FY 2014: 0.0%FY 2015: -89.9%FY 2016: 100.0%FY 2017: -38.7%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 80.1%FY 2023: 77.3%
FY 2014 5y median 100.0% FY 2023
Operating Margin -1298.2%
FY 2014: 0.0%FY 2015: -9406.9%FY 2016: -15130.3%FY 2017: -4966.9%FY 2018: -3136.4%FY 2019: -3922.4%FY 2020: -545.3%FY 2021: -423.3%FY 2022: -913.1%FY 2023: -1298.2%
FY 2014 5y median -913.1% FY 2023
Net Margin -1656.3%
FY 2014: 0.0%FY 2015: -9406.3%FY 2016: -15060.9%FY 2017: -4905.5%FY 2018: -3038.0%FY 2019: -3806.2%FY 2020: -556.8%FY 2021: -368.5%FY 2022: -636.1%FY 2023: -1656.3%
FY 2014 5y median -636.1% FY 2023
ROE -987.7%
FY 2014: -22.3%FY 2015: -87.6%FY 2016: -59.2%FY 2017: -82.7%FY 2018: -79.2%FY 2019: -95.3%FY 2020: -92.8%FY 2021: -101.6%FY 2022: -74.1%FY 2023: -987.7%
FY 2014 5y median -95.3% FY 2023
ROIC -91.8%
FY 2014: -22.3%FY 2015: -83.3%FY 2016: -58.5%FY 2017: -82.7%FY 2018: -73.7%FY 2019: -60.9%FY 2020: -44.2%FY 2021: -64.8%FY 2022: -63.0%FY 2023: -91.8%
FY 2014 5y median -63.0% FY 2023
ROA -97.9%
FY 2014: -21.8%FY 2015: -68.3%FY 2016: -52.3%FY 2017: -68.8%FY 2018: -58.3%FY 2019: -50.3%FY 2020: -39.4%FY 2021: -47.3%FY 2022: -38.7%FY 2023: -97.9%
FY 2014 5y median -47.3% FY 2023

Growth (YoY)

Revenue -33.2%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 247.3%FY 2018: 86.2%FY 2019: -3.3%FY 2020: 661.5%FY 2021: 55.6%FY 2022: -36.6%FY 2023: -33.2%
FY 2014 FY 2023
Operating Income 5.1%
FY 2014: -55.6%FY 2015: -122.0%FY 2016: -60.8%FY 2017: -14.0%FY 2018: -17.6%FY 2019: -20.9%FY 2020: -5.9%FY 2021: -20.8%FY 2022: -36.7%FY 2023: 5.1%
FY 2014 FY 2023
EPS (diluted) 22.4%
FY 2014: 35.8%FY 2015: -122.0%FY 2016: 68.8%FY 2017: 43.5%FY 2018: 10.3%FY 2019: 1.6%FY 2020: 2.7%FY 2021: 24.2%FY 2022: 45.9%FY 2023: 22.4%
FY 2014 FY 2023
Free Cash Flow 11.5%
FY 2014: -50.8%FY 2015: -98.9%FY 2016: -77.1%FY 2017: -6.3%FY 2018: 8.5%FY 2019: -74.8%FY 2020: 16.7%FY 2021: -66.0%FY 2022: -23.3%FY 2023: 11.5%
FY 2014 FY 2023

Financial Health

Current Ratio 4.0×
FY 2014: 48.4×FY 2015: 4.6×FY 2016: 8.9×FY 2017: 5.9×FY 2018: 5.2×FY 2019: 4.9×FY 2020: 6.2×FY 2021: 4.3×FY 2022: 6.9×FY 2023: 4.0×
FY 2014 5y median 4.9× FY 2023
Quick Ratio 4.0×
FY 2014: 48.4×FY 2015: 4.6×FY 2016: 8.9×FY 2017: 5.9×FY 2018: 5.2×FY 2019: 4.9×FY 2020: 6.2×FY 2021: 4.3×FY 2022: 6.9×FY 2023: 4.0×
FY 2014 5y median 4.9× FY 2023
Debt / Equity 3.7×
FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.3×FY 2020: 0.7×FY 2021: 0.8×FY 2022: 0.5×FY 2023: 3.7×
FY 2014 5y median 0.7× FY 2023
Net Debt / EBITDA 0.5×
FY 2014: 4.6×FY 2015: 1.2×FY 2016: 1.3×FY 2017: 0.6×FY 2018: 0.8×FY 2019: 0.2×FY 2020: 1.4×FY 2021: 0.3×FY 2022: 1.2×FY 2023: 0.5×
FY 2014 5y median 0.5× FY 2023
Interest Coverage -25.2×
FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: -64296×FY 2019: 0.0×FY 2020: -45.9×FY 2021: -25.4×FY 2022: -32.9×FY 2023: -25.2×
FY 2014 5y median -25.4× FY 2023

Dividends

Dividend Yield 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31